Aditxt, Inc. completed the acquisition of Ignite Proteomics, LLC on March 11, 2026, paying $36 million in preferred stock and $475,000 in cash. This event helps Aditxt meet compliance with Nasdaq's equity requirements after potential delisting concerns.